25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Supriya Lifescience Ltd
Buy, Hold or Sell?

Let's analyze Supriya Lifescience Ltd together

I guess you are interested in Supriya Lifescience Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Supriya Lifescience Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Supriya Lifescience Ltd

I send you an email if I find something interesting about Supriya Lifescience Ltd.

1. Quick Overview

1.1. Quick analysis of Supriya Lifescience Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Supriya Lifescience Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR101.31
Expected worth in 1 year
INR158.92
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR60.01
Return On Investment
7.9%

For what price can you sell your share?

Current Price per Share
INR757.85
Expected price per share
INR600.00 - INR
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Supriya Lifescience Ltd (5 min.)




Live pricePrice per Share (EOD)
INR757.85
Intrinsic Value Per Share
INR-124.14 - INR-149.19
Total Value Per Share
INR-22.84 - INR-47.88

2.2. Growth of Supriya Lifescience Ltd (5 min.)




Is Supriya Lifescience Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$96.2m$82.5m$13.6m14.2%

How much money is Supriya Lifescience Ltd making?

Current yearPrevious yearGrowGrow %
Making money$14m$10.6m$3.4m24.6%
Net Profit Margin20.9%19.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Supriya Lifescience Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#362 / 950

Most Revenue
#102 / 950

Most Profit
#63 / 950
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Supriya Lifescience Ltd?

Welcome investor! Supriya Lifescience Ltd's management wants to use your money to grow the business. In return you get a share of Supriya Lifescience Ltd.

First you should know what it really means to hold a share of Supriya Lifescience Ltd. And how you can make/lose money.

Speculation

The Price per Share of Supriya Lifescience Ltd is INR757.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Supriya Lifescience Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Supriya Lifescience Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR101.31. Based on the TTM, the Book Value Change Per Share is INR14.40 per quarter. Based on the YOY, the Book Value Change Per Share is INR10.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.60 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Supriya Lifescience Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.170.0%0.170.0%0.130.0%0.160.0%0.160.0%
Usd Book Value Change Per Share0.170.0%0.170.0%0.120.0%0.240.0%0.240.0%
Usd Dividend Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.180.0%0.180.0%0.130.0%0.250.0%0.250.0%
Usd Price Per Share3.91-3.91-2.25-2.40-2.40-
Price to Earnings Ratio22.42-22.42-17.08-13.13-13.13-
Price-to-Total Gains Ratio22.11-22.11-17.32-16.91-16.91-
Price to Book Ratio3.27-3.27-2.19-2.38-2.38-
Price-to-Total Gains Ratio22.11-22.11-17.32-16.91-16.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.94263
Number of shares111
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.170.24
Usd Total Gains Per Share0.180.25
Gains per Quarter (111 shares)19.6527.70
Gains per Year (111 shares)78.60110.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1375695106101
261511489212212
3922622714318323
41330230619425434
51637738523531545
61945346428637656
72252854332743767
82560462237849878
92867970142955989
10317557804610621100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Supriya Lifescience Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.40214.4020%10.409+38%20.262-29%20.262-29%
Book Value Per Share--101.309101.3090%86.908+17%63.334+60%63.334+60%
Current Ratio--5.1735.1730%4.854+7%3.622+43%3.622+43%
Debt To Asset Ratio--0.1150.1150%0.147-22%0.276-58%0.276-58%
Debt To Equity Ratio--0.1300.1300%0.173-25%0.482-73%0.482-73%
Dividend Per Share--0.6000.6000%0.6000%0.886-32%0.886-32%
Eps--14.80014.8000%11.165+33%13.861+7%13.861+7%
Free Cash Flow Per Share---4.019-4.0190%-5.245+30%0.933-531%0.933-531%
Free Cash Flow To Equity Per Share---4.019-4.0190%-5.245+30%3.565-213%3.565-213%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---149.187--------
Intrinsic Value_10Y_min---124.145--------
Intrinsic Value_1Y_max---6.020--------
Intrinsic Value_1Y_min---5.849--------
Intrinsic Value_3Y_max---24.892--------
Intrinsic Value_3Y_min---23.387--------
Intrinsic Value_5Y_max---51.970--------
Intrinsic Value_5Y_min---47.161--------
Market Cap60993889980.000+56%26700168900.00026700168900.0000%15348069960.000+74%16343642196.000+63%16343642196.000+63%
Net Profit Margin--0.2090.2090%0.195+7%0.251-17%0.251-17%
Operating Margin----0%0.254-100%0.281-100%0.281-100%
Operating Ratio--1.1131.1130%1.138-2%1.101+1%1.101+1%
Pb Ratio7.481+56%3.2753.2750%2.194+49%2.382+37%2.382+37%
Pe Ratio51.206+56%22.41622.4160%17.081+31%13.126+71%13.126+71%
Price Per Share757.850+56%331.750331.7500%190.700+74%203.070+63%203.070+63%
Price To Free Cash Flow Ratio-188.555-128%-82.540-82.5400%-36.359-56%-95.238+15%-95.238+15%
Price To Total Gains Ratio50.518+56%22.11422.1140%17.323+28%16.912+31%16.912+31%
Quick Ratio--1.5971.5970%1.706-6%1.353+18%1.353+18%
Return On Assets--0.1290.1290%0.110+18%0.188-31%0.188-31%
Return On Equity--0.1460.1460%0.128+14%0.295-50%0.295-50%
Total Gains Per Share--15.00215.0020%11.009+36%21.148-29%21.148-29%
Usd Book Value--96213306.00096213306.0000%82536044.000+17%60148045.600+60%60148045.600+60%
Usd Book Value Change Per Share--0.1700.1700%0.123+38%0.239-29%0.239-29%
Usd Book Value Per Share--1.1951.1950%1.026+17%0.747+60%0.747+60%
Usd Dividend Per Share--0.0070.0070%0.0070%0.010-32%0.010-32%
Usd Eps--0.1750.1750%0.132+33%0.164+7%0.164+7%
Usd Free Cash Flow---3817064.000-3817064.0000%-4981134.000+30%886463.200-531%886463.200-531%
Usd Free Cash Flow Per Share---0.047-0.0470%-0.062+30%0.011-531%0.011-531%
Usd Free Cash Flow To Equity Per Share---0.047-0.0470%-0.062+30%0.042-213%0.042-213%
Usd Market Cap719727901.764+56%315061993.020315061993.0200%181107225.528+74%192854977.913+63%192854977.913+63%
Usd Price Per Share8.943+56%3.9153.9150%2.250+74%2.396+63%2.396+63%
Usd Profit--14055452.00014055452.0000%10603126.000+33%13169083.200+7%13169083.200+7%
Usd Revenue--67303660.00067303660.0000%54390684.000+24%53045531.200+27%53045531.200+27%
Usd Total Gains Per Share--0.1770.1770%0.130+36%0.250-29%0.250-29%
 EOD+5 -3MRQTTM+0 -0YOY+28 -55Y+15 -2010Y+15 -20

3.3 Fundamental Score

Let's check the fundamental score of Supriya Lifescience Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1551.206
Price to Book Ratio (EOD)Between0-17.481
Net Profit Margin (MRQ)Greater than00.209
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.597
Current Ratio (MRQ)Greater than15.173
Debt to Asset Ratio (MRQ)Less than10.115
Debt to Equity Ratio (MRQ)Less than10.130
Return on Equity (MRQ)Greater than0.150.146
Return on Assets (MRQ)Greater than0.050.129
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Supriya Lifescience Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.383
Ma 20Greater thanMa 50685.915
Ma 50Greater thanMa 100619.200
Ma 100Greater thanMa 200553.642
OpenGreater thanClose781.700
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Supriya Lifescience Ltd

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-11-16 10:19:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Supriya Lifescience Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 20.9% means that ₹0.21 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Supriya Lifescience Ltd:

  • The MRQ is 20.9%. The company is making a huge profit. +2
  • The TTM is 20.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.9%TTM20.9%0.0%
TTM20.9%YOY19.5%+1.4%
TTM20.9%5Y25.1%-4.2%
5Y25.1%10Y25.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9%-110.9%+131.8%
TTM20.9%-214.4%+235.3%
YOY19.5%-210.0%+229.5%
5Y25.1%-339.1%+364.2%
10Y25.1%-464.5%+489.6%
4.3.1.2. Return on Assets

Shows how efficient Supriya Lifescience Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • 12.9% Return on Assets means that Supriya Lifescience Ltd generated ₹0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Supriya Lifescience Ltd:

  • The MRQ is 12.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 12.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ12.9%TTM12.9%0.0%
TTM12.9%YOY11.0%+2.0%
TTM12.9%5Y18.8%-5.9%
5Y18.8%10Y18.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.9%-11.2%+24.1%
TTM12.9%-11.7%+24.6%
YOY11.0%-11.3%+22.3%
5Y18.8%-12.7%+31.5%
10Y18.8%-14.2%+33.0%
4.3.1.3. Return on Equity

Shows how efficient Supriya Lifescience Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • 14.6% Return on Equity means Supriya Lifescience Ltd generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Supriya Lifescience Ltd:

  • The MRQ is 14.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.6%TTM14.6%0.0%
TTM14.6%YOY12.8%+1.8%
TTM14.6%5Y29.5%-14.9%
5Y29.5%10Y29.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6%-14.2%+28.8%
TTM14.6%-15.8%+30.4%
YOY12.8%-14.2%+27.0%
5Y29.5%-18.5%+48.0%
10Y29.5%-19.5%+49.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Supriya Lifescience Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Supriya Lifescience Ltd is operating .

  • Measures how much profit Supriya Lifescience Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Supriya Lifescience Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY25.4%-25.4%
TTM-5Y28.1%-28.1%
5Y28.1%10Y28.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM--306.4%+306.4%
YOY25.4%-221.9%+247.3%
5Y28.1%-387.1%+415.2%
10Y28.1%-498.7%+526.8%
4.3.2.2. Operating Ratio

Measures how efficient Supriya Lifescience Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.11 means that the operating costs are ₹1.11 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Supriya Lifescience Ltd:

  • The MRQ is 1.113. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.113. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.113TTM1.1130.000
TTM1.113YOY1.138-0.025
TTM1.1135Y1.101+0.012
5Y1.10110Y1.1010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1132.465-1.352
TTM1.1133.244-2.131
YOY1.1383.298-2.160
5Y1.1014.788-3.687
10Y1.1016.517-5.416
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Supriya Lifescience Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Supriya Lifescience Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.17 means the company has ₹5.17 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Supriya Lifescience Ltd:

  • The MRQ is 5.173. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.173. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.173TTM5.1730.000
TTM5.173YOY4.854+0.320
TTM5.1735Y3.622+1.551
5Y3.62210Y3.6220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1733.610+1.563
TTM5.1733.877+1.296
YOY4.8544.633+0.221
5Y3.6225.938-2.316
10Y3.6226.265-2.643
4.4.3.2. Quick Ratio

Measures if Supriya Lifescience Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.60 means the company can pay off ₹1.60 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Supriya Lifescience Ltd:

  • The MRQ is 1.597. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.597. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.597TTM1.5970.000
TTM1.597YOY1.706-0.109
TTM1.5975Y1.353+0.244
5Y1.35310Y1.3530.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5973.048-1.451
TTM1.5973.426-1.829
YOY1.7064.449-2.743
5Y1.3535.927-4.574
10Y1.3536.424-5.071
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Supriya Lifescience Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Supriya Lifescience Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Supriya Lifescience Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Supriya Lifescience Ltd assets are financed with 11.5% credit (debt) and the remaining percentage (100% - 11.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Supriya Lifescience Ltd:

  • The MRQ is 0.115. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.115. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.115TTM0.1150.000
TTM0.115YOY0.147-0.032
TTM0.1155Y0.276-0.161
5Y0.27610Y0.2760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1150.353-0.238
TTM0.1150.346-0.231
YOY0.1470.311-0.164
5Y0.2760.366-0.090
10Y0.2760.383-0.107
4.5.4.2. Debt to Equity Ratio

Measures if Supriya Lifescience Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.0% means that company has ₹0.13 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Supriya Lifescience Ltd:

  • The MRQ is 0.130. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.130. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.1300.000
TTM0.130YOY0.173-0.043
TTM0.1305Y0.482-0.352
5Y0.48210Y0.4820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1300.395-0.265
TTM0.1300.435-0.305
YOY0.1730.380-0.207
5Y0.4820.451+0.031
10Y0.4820.493-0.011
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Supriya Lifescience Ltd generates.

  • Above 15 is considered overpriced but always compare Supriya Lifescience Ltd to the Biotechnology industry mean.
  • A PE ratio of 22.42 means the investor is paying ₹22.42 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Supriya Lifescience Ltd:

  • The EOD is 51.206. Based on the earnings, the company is expensive. -2
  • The MRQ is 22.416. Based on the earnings, the company is fair priced.
  • The TTM is 22.416. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD51.206MRQ22.416+28.791
MRQ22.416TTM22.4160.000
TTM22.416YOY17.081+5.335
TTM22.4165Y13.126+9.290
5Y13.12610Y13.1260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD51.206-2.251+53.457
MRQ22.416-2.398+24.814
TTM22.416-3.147+25.563
YOY17.081-3.237+20.318
5Y13.126-6.021+19.147
10Y13.126-6.731+19.857
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Supriya Lifescience Ltd:

  • The EOD is -188.555. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -82.540. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -82.540. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-188.555MRQ-82.540-106.015
MRQ-82.540TTM-82.5400.000
TTM-82.540YOY-36.359-46.182
TTM-82.5405Y-95.238+12.698
5Y-95.23810Y-95.2380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-188.555-2.954-185.601
MRQ-82.540-3.234-79.306
TTM-82.540-3.730-78.810
YOY-36.359-4.523-31.836
5Y-95.238-8.196-87.042
10Y-95.238-9.244-85.994
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Supriya Lifescience Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.27 means the investor is paying ₹3.27 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Supriya Lifescience Ltd:

  • The EOD is 7.481. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.275. Based on the equity, the company is fair priced.
  • The TTM is 3.275. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.481MRQ3.275+4.206
MRQ3.275TTM3.2750.000
TTM3.275YOY2.194+1.080
TTM3.2755Y2.382+0.892
5Y2.38210Y2.3820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.4811.931+5.550
MRQ3.2752.039+1.236
TTM3.2752.343+0.932
YOY2.1942.431-0.237
5Y2.3823.698-1.316
10Y2.3824.362-1.980
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets9,212,380
Total Liabilities1,058,710
Total Stockholder Equity8,153,670
 As reported
Total Liabilities 1,058,710
Total Stockholder Equity+ 8,153,670
Total Assets = 9,212,380

Assets

Total Assets9,212,380
Total Current Assets3,978,040
Long-term Assets5,234,330
Total Current Assets
Cash And Cash Equivalents 683,490
Short-term Investments 111,160
Net Receivables 1,116,830
Inventory 852,490
Other Current Assets 1,207,220
Total Current Assets  (as reported)3,978,040
Total Current Assets  (calculated)3,971,190
+/- 6,850
Long-term Assets
Property Plant Equipment 4,573,010
Long-term Assets Other 6,810
Long-term Assets  (as reported)5,234,330
Long-term Assets  (calculated)4,579,820
+/- 654,510

Liabilities & Shareholders' Equity

Total Current Liabilities768,940
Long-term Liabilities289,770
Total Stockholder Equity8,153,670
Total Current Liabilities
Accounts payable 595,690
Other Current Liabilities 149,180
Total Current Liabilities  (as reported)768,940
Total Current Liabilities  (calculated)744,870
+/- 24,070
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt54,880
Long-term Liabilities Other 10
Long-term Liabilities  (as reported)289,770
Long-term Liabilities  (calculated)54,890
+/- 234,880
Total Stockholder Equity
Total Stockholder Equity (as reported)8,153,670
Total Stockholder Equity (calculated)0
+/- 8,153,670
Other
Capital Stock160,970
Common Stock Shares Outstanding 80,483
Net Invested Capital 8,153,670
Net Working Capital 3,209,100
Property Plant and Equipment Gross 4,573,010



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-31
> Total Assets 
3,364,300
4,458,240
7,347,620
8,202,770
9,212,380
9,212,3808,202,7707,347,6204,458,2403,364,300
   > Total Current Assets 
1,979,930
2,654,630
4,975,440
4,648,870
3,978,040
3,978,0404,648,8704,975,4402,654,6301,979,930
       Cash And Cash Equivalents 
15,430
310,720
1,657,750
852,510
683,490
683,490852,5101,657,750310,72015,430
       Short-term Investments 
731,620
583,713
591,550
787,370
111,160
111,160787,370591,550583,713731,620
       Net Receivables 
524,860
735,000
1,151,830
846,640
1,116,830
1,116,830846,6401,151,830735,000524,860
       Inventory 
494,580
724,800
923,120
1,157,700
852,490
852,4901,157,700923,120724,800494,580
       Other Current Assets 
82,977
285,147
512,769
922,035
1,207,220
1,207,220922,035512,769285,14782,977
   > Long-term Assets 
1,384,370
1,794,250
2,372,180
3,553,900
5,234,330
5,234,3303,553,9002,372,1801,794,2501,384,370
       Property Plant Equipment 
1,350,070
1,759,160
2,316,740
3,280,600
4,573,010
4,573,0103,280,6002,316,7401,759,1601,350,070
       Intangible Assets 
31,980
30,210
15,080
11,050
0
011,05015,08030,21031,980
       Other Assets 
1,770
11,240
39,820
0
0
0039,82011,2401,770
> Total Liabilities 
1,872,370
1,768,830
1,190,750
1,208,190
1,058,710
1,058,7101,208,1901,190,7501,768,8301,872,370
   > Total Current Liabilities 
1,553,880
1,460,190
996,990
957,800
768,940
768,940957,800996,9901,460,1901,553,880
       Short Long Term Debt 
798,170
701,290
212,950
166,250
0
0166,250212,950701,290798,170
       Accounts payable 
493,920
510,220
489,720
642,280
595,690
595,690642,280489,720510,220493,920
       Other Current Liabilities 
240,740
213,800
256,490
118,150
149,180
149,180118,150256,490213,800240,740
   > Long-term Liabilities 
318,490
308,640
193,760
250,390
289,770
289,770250,390193,760308,640318,490
       Long term Debt 
23,930
0
0
0
0
000023,930
       Capital Lease Obligations Min Short Term Debt
23,100
20,650
61,200
58,430
54,880
54,88058,43061,20020,65023,100
       Other Liabilities 
271,460
287,990
140,810
0
0
00140,810287,990271,460
       Long-term Liabilities Other 
0
10
10
0
10
10010100
> Total Stockholder Equity
1,491,930
2,689,420
6,156,880
6,994,590
8,153,670
8,153,6706,994,5906,156,8802,689,4201,491,930
   Common Stock
146,370
146,370
160,970
0
0
00160,970146,370146,370
   Retained Earnings 
1,345,560
2,539,460
4,010,510
4,848,220
0
04,848,2204,010,5102,539,4601,345,560
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 0-10-1000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,703,700
Cost of Revenue-2,217,410
Gross Profit3,486,2903,486,290
 
Operating Income (+$)
Gross Profit3,486,290
Operating Expense-4,132,050
Operating Income1,571,650-645,760
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense4,132,0500
 
Net Interest Income (+$)
Interest Income0
Interest Expense-21,100
Other Finance Cost-0
Net Interest Income-21,100
 
Pretax Income (+$)
Operating Income1,571,650
Net Interest Income-21,100
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,656,9001,571,650
EBIT - interestExpense = -21,100
1,191,140
1,212,240
Interest Expense21,100
Earnings Before Interest and Taxes (EBIT)01,678,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,656,900
Tax Provision-465,760
Net Income From Continuing Ops1,191,1401,191,140
Net Income1,191,140
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net021,100
 

Technical Analysis of Supriya Lifescience Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Supriya Lifescience Ltd. The general trend of Supriya Lifescience Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Supriya Lifescience Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Supriya Lifescience Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 689.65 > 603.40 > 600.00.

Tweet this
Supriya Lifescience Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Supriya Lifescience Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Supriya Lifescience Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Supriya Lifescience Ltd. The current macd is 49.46.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Supriya Lifescience Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Supriya Lifescience Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Supriya Lifescience Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Supriya Lifescience Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSupriya Lifescience Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Supriya Lifescience Ltd. The current adx is 33.74.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Supriya Lifescience Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Supriya Lifescience Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Supriya Lifescience Ltd. The current sar is 660.11.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Supriya Lifescience Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Supriya Lifescience Ltd. The current rsi is 66.38. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Supriya Lifescience Ltd Daily Relative Strength Index (RSI) ChartSupriya Lifescience Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Supriya Lifescience Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Supriya Lifescience Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Supriya Lifescience Ltd Daily Stochastic Oscillator ChartSupriya Lifescience Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Supriya Lifescience Ltd. The current cci is 106.28.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Supriya Lifescience Ltd Daily Commodity Channel Index (CCI) ChartSupriya Lifescience Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Supriya Lifescience Ltd. The current cmo is 30.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Supriya Lifescience Ltd Daily Chande Momentum Oscillator (CMO) ChartSupriya Lifescience Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Supriya Lifescience Ltd. The current willr is -32.83322461.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Supriya Lifescience Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Supriya Lifescience Ltd Daily Williams %R ChartSupriya Lifescience Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Supriya Lifescience Ltd.

Supriya Lifescience Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Supriya Lifescience Ltd. The current atr is 38.62.

Supriya Lifescience Ltd Daily Average True Range (ATR) ChartSupriya Lifescience Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Supriya Lifescience Ltd. The current obv is 3,830,159.

Supriya Lifescience Ltd Daily On-Balance Volume (OBV) ChartSupriya Lifescience Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Supriya Lifescience Ltd. The current mfi is 81.63.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Supriya Lifescience Ltd Daily Money Flow Index (MFI) ChartSupriya Lifescience Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Supriya Lifescience Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside

6.3. Candlestick Patterns

Supriya Lifescience Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Supriya Lifescience Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.383
Ma 20Greater thanMa 50685.915
Ma 50Greater thanMa 100619.200
Ma 100Greater thanMa 200553.642
OpenGreater thanClose781.700
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Supriya Lifescience Ltd with someone you think should read this too:
  • Are you bullish or bearish on Supriya Lifescience Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Supriya Lifescience Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Supriya Lifescience Ltd

I send you an email if I find something interesting about Supriya Lifescience Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Supriya Lifescience Ltd.

Receive notifications about Supriya Lifescience Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.